Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents

Cited by (346)

Items 301–346 of 346

1. Substytucja immunoglobulin u chorych na przewlekłą białaczkę limfocytową i szpiczaka plazmocytowego
   Krzysztof Jamroziak, Agnieszka Końska · 2015 · Acta Haematologica Polonica
2. ACID SUPPRESSION AS A RISK FACTOR FOR COMPLICATIONS AMONG INDIVIDUALS DIAGNOSED WITH CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA AT NAVAL MEDICAL CENTER SAN DIEGO
   Rosemary Grace Hurford Morrison · 2011 · California State University ScholarWorks (system-wide DSpace)
3. Clinical and Population-based Studies in Multiple Myeloma and Monoclonal Gammopathy – Focus on Infections
   Cecilie Hveding Blimark · 2014 · Gothenburg University Publications Electronic Archive (Gothenburg University)
4. Pulmonary toxicity related with chemotherapeutic agents
   ABID I KHOKAR, Jeffrey Schneider, Cyril Cheriyan, Zubair Ali, GIRISH BALACHANDRAN NAIR · 2014 · Journal of symptoms and signs
5. Incidence et étiologies des pneumopathies infectieuses chez les patients porteurs d'hémopathies malignes
   Audrey Simon-Hansma · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
6. Promoting quality of life for patients with myeloma
   Maura Dowling, Mary Kelly, Teresa Meenaghan · 2013 · Cancer Nursing Practice
7. Management of multiple myeloma in older people
   E. Bolaños, Belén Íñigo, Celina Benavente, Rafael Martínez · 2014 · Reviews in Clinical Gerontology
8. Infectious immunity and pneumococcal vaccine responses in multiple myeloma and related disorders
   Johanna Karlsson · 2016 · Gothenburg University Publications Electronic Archive (Gothenburg University)
9. Special Considerations for Long-Term Survivors After Hematopoietic Stem Cell Transplantation
   Merav Bar, Mary E.D. Flowers · 2016 · Springer eBooks
10. Article Open Access
    Holly Lawford‐Smith · 2015
11. Peripheral Neuropathy and Diarrhea Symptoms in Multiple Myeloma
    Beth M Faiman · 2014 · OhioLink ETD Center (Ohio Library and Information Network)
12. A 43-year-old female with new onset vertigo
    Rebecca S. George, Emad A. S. Massoud · 2016 · Dalhousie Medical Journal
13. Infections in Cancer
    Andrea J. Zimmer, Alison G. Freifeld · 2018 · Springer eBooks
14. Natural killer cells, multiple myeloma, and daratumumab : a love-hate relationship
    Michael Chrobok · 2019 · Figshare
15. A case of psoriatic arthritis with type I cryoglobulinemia associated with multiple myeloma
    Aiko Yamazaki, Keita Fujikawa, Yushiro Endo, Emi Matsuo, Yoko Yokoyama, Akinari Mizokami, Masahiro Nakashima, Atsushi Kawakami · 2019 · Modern Rheumatology Case Reports
16. Relevance and management of secondary hypogammaglobulinema in clinical practice
    Dmitry Balashov · 2019 · Pediatric Hematology/Oncology and Immunopathology
17. Tedizolid Use in Immunocompromised Patients.
    Zachary Pedretti, Jacqueline M. Chen, Susanne G. Barnett · 2018 · Europe PMC (PubMed Central)
18. Resolution of high output pulmonary edema due to hyperviscosity with plasma exchange in a patient with multiple myeloma- a case report
    Charanpreet Singh, Deepesh Pravinkumar Lad, Arihant Jain, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra · 2020 · Transfusion and Apheresis Science
19. The Incidence and Timing of Blood Cultures in Multiple Myeloma – Results from a Retrospective, Single Center, Real-World Study
    Agoston Gyula Szabo, Katrine Fladeland Iversen, Flemming Schønning Rosenvinge, Sören Möller, Torben Plesner · 2020 · Clinical Hematology International
20. Drug-Induced Modulation of T Lymphocytes as a Potential Mechanism of Susceptibility to Infections in Patients with Multiple Myeloma During Bortezomib Therapy
    Juan LiYing, HuangDong Zheng, Mei ChenZhenhai Zhou · 2015
21. Infection in the CD38 and Anti-BCMA Era: Prevention and Treatment
    Raje Noopur · 2021 · Clinical Lymphoma Myeloma & Leukemia
22. What the Intensivists Need to Know About Critically Ill Myeloma Patients
    Ranjit K. Nair, Krina K. Patel · 2018 · Springer eBooks
23. Multipel myeloom
    Niels W.C.J. van de Donk, Ellen van der Spek · 2013 · Bohn Stafleu van Loghum eBooks
24. Tuberculosis during lenalidomide maintenance in a patient with multiple myeloma
    Gladys Ibarra, Josep‐María Ribera, Laura Abril · 2021 · Medicina Clínica (English Edition)
25. Bacterial meningitis in patients with multiple myeloma: a prospective nationwide cohort study and review of the literature
    Fereshte Sheybani, Matthijs C. Brouwer, Diederik van de Beek · 2022 · International Journal of Infectious Diseases
26. Plasma Cell Disorders
    Andrew Jenho Yee, Teru Hideshima, Noopur S Raje, Kenneth Carl Anderson · 2022 · Wiley eBooks
27. Infections and Paraproteinemia
    Alessandro Visentin, Matilde Rocchi, Anna Giulia Salvadori, Paola Del Bravo, Elda Righi · 2022 · Springer eBooks
28. COVID-19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA (REVIEW ARTICLE)
    Галанин Владислав Васильевич, Ирина Владимировна Демко, Бахтина Варвара Ивановна, A.A. Gordo, Д. В. Белоногов, E.S. Kochergina · 2022 · Bulletin of Medical Science
29. Role of Endoscopic Techniques in the Diagnosis of Complications of Allogeneic Hematopoietic Stem Cell Transplantation: A Review of the Literature
    Ayrton Bangolo, Shraboni Dey, Vignesh Krishnan Nagesh, Kabir S. Gumer, Lida Avetisyan, Saima Islam, MONIKA SAHOTRA, Melissa Millett, Budoor Alqinai, Silvanna Pender et al. · 2024 · Journal of Clinical Medicine
30. Associação entre polimorfismos genéticos e complicações precoces pós- transplante autólogo de células tronco hematopoiéticas em pacientes adultos com linfoma ou mieloma múltiplo
    Luciana Tomanik Cardozo de Mello Tucunduva · 2024 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
31. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination
    Ksenia V. Zornikova, N. O. Ivanova, Olga A. Aleshina, Savely A. Sheetikov, Vassa D Davydova, Боголюбова Аполлинария Васильевна · 2024 · Гематология и трансфузиология
32. When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study
    Xincheng Jiang, Xiaoyan Han, Fengyan Jin, Gang An, Jian Hou, Jingsong He, Qingming Wang, Wenjun Wu, Yi Zhao, Songfu Jiang et al. · 2024 · Hematology
33. Prognosis of hepatitis B virus reactivation in newly diagnosed multiple myeloma in modern era therapy: a retrospective study
    Weiran Lv, Xiaojin Li, Jingbo Xu, Yun Wang, Han-Ying Huang, Fang Hu, Yingying Cui, Yuanbin Song, Lezong Chen, Bingyi Wu et al. · 2024 · PeerJ
34. Visceral leishmaniasis in heavily pretreated multiple myeloma patients a case series of 17 patients from the Mediterranean Coast of Spain
    Ana Monreal Bernal, Mercedes Berenguer, Pedro Ortiz Salvador, Marina Suarez Terron, Ana Bataller Alfonso, Soledad Delgado Palacio, María Leonor Senent Peris, Monica Roig Pellicer, Ana Villalba Valenzuela, Carmen Benet Campos et al. · 2025 · Annals of Medicine
35. Plasma cell disorders
    Caitlin L. Costello, Rafaël Fonseca · 2022
36. Plasma cell disorders: monoclonal gammopathy of undetermined significance and multiple myeloma
    Caitlin L. Costello · 2025
37. Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience
    Angela Rago, Francesca Fioritoni, Carmine Liberatore, Stefano Pulini, Francesca Fazio, Maria Teresa Petrucci, Valerio De Stefano, Elena Giulia Rossi, Tommaso Zà, Francesca Di Landro et al. · 2025 · Annals of Hematology
38. Additional file 1 of Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
    Balmaceda, Nicole, Aziz, Muhammad, Chandrasekar, Viveksandeep Thoguluva, Brian Lee McClune, Suman Kambhampati, Leyla Osman Shune, Abdallah, Al-Ola, Faiz Anwer, Aneela Majeed, Muzaffar H. Qazilbash et al. · 2021 · Figshare
39. iPREFER: Patients’ Experiences and Preference of Treatment for Multiple Myeloma Following Multiple Lines of Treatment – A Qualitative Study
    Melissa Betty Perry, Ramsay Lochhead Devaraj, Kate Law, Fay Ashby, Sally Taylor · 2026 · Patient Preference and Adherence
40. Prospective Study of Cytomegalovirus Reactivation in Patients With Multiple Myeloma Receiving Anti-CD38 and BCMA Therapies
    Emily Baneman, Samantha E. Jacobs, Meenakshi M. Rana, Larysa Sanchez, Hulya Kocyigit, Erin Moshier · 2026 · Clinical Lymphoma Myeloma & Leukemia
41. Kidney Transplantation Post–Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma
    Zahraa Khan, Darshana M. Dadhania, Eugène Brailovski, Heather Jolie Landau, Aisha Shaikh · 2026 · American Journal of Kidney Diseases
42. Practical recommendations for infectious prophylaxis and vaccination in multiple myeloma patients
    Rui Bergantim, Adriana Isabel Roque, Ana Jorge, José Guilherme Freitas, Mariana Trigo Miranda, Marta Nunes, Alina Ionita, Paulo Varanda Bernardo, Joana Vieira, Eliana Vale Aguiar et al. · 2026 · Frontiers in Medicine
43. Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment
    Marko Lucijanić, Jerko Orec, Ena Sorić, Anica Sabljić, Željko Jonjić, Mario Piršić, Ozren Jakšić · 2026 · Pharmaceuticals
44. Increased Risk of Infections and Mortality Following Fractures in Multiple Myeloma: A Nationwide Population‐Based Retrospective Cohort Study
    Ching‐Chi Lee, Wei‐Yi Huang, Yu‐Fen Chen, I-Szu Cheng, Kuo‐Yuan Huang · 2026 · Health Science Reports
45. Bacterial infections in Multiple Myeloma: Incidence, Causes, and the Impact of Prophylaxis in First-Line Therapy
    Asma el Mokaddam, Inger S. Nijhof, Saara Vainio, Marcel P. H. van den Broek · 2026 · Research Square
46. Die anti-tumorale Wirkung des neuen Phosphoinositid-3-Kinase-Inhibitors BAY 80-6946 auf humane Myelom-Zellen
    Janina Hensen · 2015